_Page_1.png)
Attend our mHSPC symposium fostering idea exchange between leaders and attendees.
Join us for an exciting discussion focused on metastatic hormone sensitive prostate cancer (mHSPC). Our speaker panel will guide learners through an evolutionary journey that incorporates the potential utility of novel therapies, such as AKT inhibitors, into the treatment landscape of mHSPC.